Skip to main content

Advertisement

SpringerLink
Log in

Maternal and In Utero Determinants of Type 2 Diabetes Risk in the Young

  • Pediatric Type 2 Diabetes (PS Zeitler, Section Editor)
  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

The global prevalence of diabetes mellitus has reached epidemic proportions. In 2010, it was estimated that 6.4 % of the adult population (285 million) have diabetes. In recent years, the incidence of type 2 diabetes (T2D), a condition traditionally associated with aging, has been steadily increasing among younger individuals. It is now a well-established notion that the early-life period is a critical window of development and that influences during this period can “developmentally prime” the metabolic status of the adult. This review discusses the role of maternal and in utero influences on the developmental priming of T2D risk. Both human epidemiological studies and experimental animal models are beginning to demonstrate that early dietary challenges can accelerate the onset of age-associated metabolic disturbances, including insulin resistance, T2D, obesity, hypertension, and cardiovascular disease. These findings show that poor maternal nutrition can prime a prediabetes phenotype, often manifest as insulin resistance, by very early stages of life. Thus, the maternal diet is a critical determinant of premature T2D risk. While the mechanisms that link early nutrition to age-associated metabolic decline are currently unclear, preliminary findings suggest perturbations in a number of processes involved in cellular aging, such as changes in longevity-associated Sirtuin activity, epigenetic regulation of key metabolic genes, and mitochondrial dysfunction. Preliminary studies show that pharmacological interventions in utero and dietary supplementation in early postnatal life may alleviate insulin resistance and reduce T2D risk. However, further studies are warranted to fully understand the relationship between the early environment and long-term effects on metabolism. Such mechanistic insights will facilitate strategic interventions that prevent accelerated metabolic decline and the premature onset of T2D in the current and future generations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: •• Of major importance

  1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4–14.

    Article  CAS  PubMed  Google Scholar 

  2. Sandovici I, Hammerle CM, Ozanne SE, Constancia M. Developmental and environmental epigenetic programming of the endocrine pancreas: consequences for type 2 diabetes. Cell Mol Life Sci. 2013;70:1575–95.

    Article  CAS  PubMed  Google Scholar 

  3. Liese AD, D'Agostino Jr RB, Hamman RF, Kilgo PD, Lawrence JM, Liu LL, et al. The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics. 2006;118:1510–8.

    Article  PubMed  Google Scholar 

  4. Homko CJ, Reece EA. Development of early-onset type 2 diabetes in the young: implications for child bearing. Curr Diab Rep. 2003;3:313–8.

    Article  PubMed  Google Scholar 

  5. Mokdad AH, Ford ES, Bowman BA, Nelson DE, Engelgau MM, Vinicor F, et al. Diabetes trends in the U.S.: 1990-1998. Diabetes Care. 2000;23:1278–83.

    Article  CAS  PubMed  Google Scholar 

  6. Silverstein JH, Rosenbloom AL. Type 2 diabetes in children. Curr Diab Rep. 2001;1:19–27.

    Article  CAS  PubMed  Google Scholar 

  7. Mayer-Davis EJ, Bell RA, Dabelea D, D'Agostino Jr R, Imperatore G, Lawrence JM, et al. The many faces of diabetes in American youth: type 1 and type 2 diabetes in five race and ethnic populations: the SEARCH for Diabetes in Youth Study. Diabetes Care. 2009;32 Suppl 2:S99–S101.

    Article  PubMed  Google Scholar 

  8. Hayman LL, Williams CL, Daniels SR, Steinberger J, Paridon S, Dennison BA, et al. Cardiovascular health promotion in the schools: a statement for health and education professionals and child health advocates from the Committee on Atherosclerosis, Hypertension, and Obesity in Youth (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110:2266–75.

    Article  PubMed  Google Scholar 

  9. Mayer-Davis EJ, Ma B, Lawson A, D'Agostino Jr RB, Liese AD, Bell RA, et al. Cardiovascular disease risk factors in youth with type 1 and type 2 diabetes: implications of a factor analysis of clustering. Metab Syndr Relat Disord. 2009;7:89–95.

    Article  CAS  PubMed  Google Scholar 

  10. Rodriguez BL, Fujimoto WY, Mayer-Davis EJ, Imperatore G, Williams DE, Bell RA, et al. Prevalence of cardiovascular disease risk factors in U.S. children and adolescents with diabetes: the SEARCH for diabetes in youth study. Diabetes Care. 2006;29:1891–6.

    Article  PubMed  Google Scholar 

  11. Brunt EM. Pathology of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2010;7:195–203.

    Article  PubMed  Google Scholar 

  12. Alisi A, Manco M, Vania A, Nobili V. Pediatric nonalcoholic fatty liver disease in 2009. J Pediatr. 2009;155:469–74.

    Article  PubMed  Google Scholar 

  13. Nobili V, Svegliati-Baroni G, Alisi A, Miele L, Valenti L, Vajro P. A 360-degree overview of paediatric NAFLD: recent insights. J Hepatol. 2013;58:1218–29.

    Article  PubMed  Google Scholar 

  14. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics. 2006;118:1388–93.

    Article  PubMed  Google Scholar 

  15. Nobili V, Bedogni G, Berni CR, Brambilla P, Cianfarani S, Pietrobelli A, et al. The potential role of fatty liver in paediatric metabolic syndrome: a distinct phenotype with high metabolic risk? Pediatr Obes. 2012;7:e75–80.

    Article  CAS  PubMed  Google Scholar 

  16. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest. 2000;106:171–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Cossrow N, Falkner B. Race/ethnic issues in obesity and obesity-related comorbidities. J Clin Endocrinol Metab. 2004;89:2590–4.

    Article  CAS  PubMed  Google Scholar 

  18. Arslanian S, Suprasongsin C. Insulin sensitivity, lipids, and body composition in childhood: is "syndrome X" present? J Clin Endocrinol Metab. 1996;81:1058–62.

    CAS  PubMed  Google Scholar 

  19. Weiss R, Dufour S, Taksali SE, Tamborlane WV, Petersen KF, Bonadonna RC, et al. Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet. 2003;362:951–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology. 2010;51:679–89.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Bruce KD, Byrne CD. The metabolic syndrome: common origins of a multifactorial disorder. Postgrad Med J. 2009;85:614–21.

    Article  CAS  PubMed  Google Scholar 

  22. Barker DJ, Osmond C. Low birth weight and hypertension. BMJ. 1988;297:134–5.

    Article  CAS  PubMed  Google Scholar 

  23. Hales CN, Barker DJ, Clark PM, Cox LJ, Fall C, Osmond C, et al. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ. 1991;303:1019–22.

    Article  CAS  PubMed  Google Scholar 

  24. Whincup PH, Kaye SJ, Owen CG, Huxley R, Cook DG, Anazawa S, et al. Birth weight and risk of type 2 diabetes: a systematic review. JAMA. 2008;300:2886–97.

    Article  CAS  PubMed  Google Scholar 

  25. Li Y, He Y, Qi L, Jaddoe VW, Feskens EJ, Yang X, et al. Exposure to the Chinese famine in early life and the risk of hyperglycemia and type 2 diabetes in adulthood. Diabetes. 2010;59:2400–6.

    Article  CAS  PubMed  Google Scholar 

  26. Roseboom T, de Rooij S, Painter R. The Dutch famine and its long-term consequences for adult health. Early Hum Dev. 2006;82:485–91.

    Article  PubMed  Google Scholar 

  27. Ozanne SE, Jensen CB, Tingey KJ, Storgaard H, Madsbad S, Vaag AA. Low birthweight is associated with specific changes in muscle insulin-signalling protein expression. Diabetologia. 2005;48:547–52.

    Article  CAS  PubMed  Google Scholar 

  28. Vo TX, Revesz A, Sohi G, Ma N, Hardy DB. Maternal protein restriction leads to enhanced hepatic gluconeogenic gene expression in adult male rat offspring due to impaired expression of the liver X receptor. J Endocrinol. 2013;218:85–97.

    Article  CAS  PubMed  Google Scholar 

  29. Fernandez-Twinn DS, Wayman A, Ekizoglou S, Martin MS, Hales CN, Ozanne SE. Maternal protein restriction leads to hyperinsulinemia and reduced insulin-signaling protein expression in 21-mo-old female rat offspring. Am J Physiol Regul Integr Comp Physiol. 2005;288:R368–73.

    Article  CAS  PubMed  Google Scholar 

  30. Theys N, Bouckenooghe T, Ahn MT, Remacle C, Reusens B. Maternal low-protein diet alters pancreatic islet mitochondrial function in a sex-specific manner in the adult rat. Am J Physiol Regul Integr Comp Physiol. 2009;297:R1516–25.

    Article  CAS  PubMed  Google Scholar 

  31. Remacle C, Dumortier O, Bol V, Goosse K, Romanus P, Theys N, et al. Intrauterine programming of the endocrine pancreas. Diabetes Obes Metab. 2007;9 Suppl 2:196–209.

    Article  CAS  PubMed  Google Scholar 

  32. Choi J, Li C, McDonald TJ, Comuzzie A, Mattern V, Nathanielsz PW. Emergence of insulin resistance in juvenile baboon offspring of mothers exposed to moderate maternal nutrient reduction. Am J Physiol Regul Integr Comp Physiol. 2011;301:R757–62.

    Article  CAS  PubMed  Google Scholar 

  33. Mayeur S, Lancel S, Theys N, Lukaszewski MA, Duban-Deweer S, Bastide B, et al. Maternal calorie restriction modulates placental mitochondrial biogenesis and bioenergetic efficiency: putative involvement in fetoplacental growth defects in rats. Am J Physiol Endocrinol Metab. 2013;304:E14–22.

    Article  CAS  PubMed  Google Scholar 

  34. Garofano A, Czernichow P, Breant B. Effect of aging on beta-cell mass and function in rats malnourished during the perinatal period. Diabetologia. 1999;42:711–8.

    Article  CAS  PubMed  Google Scholar 

  35. Palou M, Konieczna J, Torrens JM, Sanchez J, Priego T, Fernandes ML, et al. Impaired insulin and leptin sensitivity in the offspring of moderate caloric-restricted dams during gestation is early programmed. J Nutr Biochem. 2012;23:1627–39.

    Article  CAS  PubMed  Google Scholar 

  36. Vickers MH, Breier BH, Cutfield WS, Hofman PL, Gluckman PD. Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition. Am J Physiol Endocrinol Metab. 2000;279:E83–7.

    CAS  PubMed  Google Scholar 

  37. Desai M, Gayle D, Babu J, Ross MG. Programmed obesity in intrauterine growth-restricted newborns: modulation by newborn nutrition. Am J Physiol Regul Integr Comp Physiol. 2005;288:R91–6.

    Article  CAS  PubMed  Google Scholar 

  38. Lawlor DA, Lichtenstein P, Fraser A, Langstrom N. Does maternal weight gain in pregnancy have long-term effects on offspring adiposity? A sibling study in a prospective cohort of 146,894 men from 136,050 families. Am J Clin Nutr. 2011;94:142–8.

    Article  CAS  PubMed  Google Scholar 

  39. Yu Z, Han S, Zhu J, Sun X, Ji C, Guo X. Pre-pregnancy body mass index in relation to infant birth weight and offspring overweight/obesity: a systematic review and meta-analysis. PLoS One. 2013;8:e61627.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  40. Catalano PM, Presley L, Minium J, Hauguel-de MS. Fetuses of obese mothers develop insulin resistance in utero. Diabetes Care. 2009;32:1076–80. This study took metabolic and anthropomorphic measurements from offspring of either obese or lean mothers within 24 h of caesarean section delivery. It showed that fetuses of obese mothers developed insulin resistance in utero and suggested that maternal obesity causes a metabolic compromise already present at birth.

    Article  CAS  PubMed  Google Scholar 

  41. Buckley AJ, Keseru B, Briody J, Thompson M, Ozanne SE, Thompson CH. Altered body composition and metabolism in the male offspring of high fat-fed rats. Metabolism. 2005;54:500–7.

    Article  CAS  PubMed  Google Scholar 

  42. Srinivasan M, Katewa SD, Palaniyappan A, Pandya JD, Patel MS. Maternal high-fat diet consumption results in fetal malprogramming predisposing to the onset of metabolic syndrome-like phenotype in adulthood. Am J Physiol Endocrinol Metab. 2006;291:E792–9.

    Article  CAS  PubMed  Google Scholar 

  43. Elahi MM, Cagampang FR, Mukhtar D, Anthony FW, Ohri SK, Hanson MA. Long-term maternal high-fat feeding from weaning through pregnancy and lactation predisposes offspring to hypertension, raised plasma lipids and fatty liver in mice. Br J Nutr. 2009;102:514–9.

    Article  CAS  PubMed  Google Scholar 

  44. Bruce KD, Cagampang FR, Argenton M, Zhang J, Ethirajan PL, Burdge GC, et al. Maternal high-fat feeding primes steatohepatitis in adult mice offspring, involving mitochondrial dysfunction and altered lipogenesis gene expression. Hepatology. 2009;50:1796–808.

    Article  CAS  PubMed  Google Scholar 

  45. Armitage JA, Lakasing L, Taylor PD, Balachandran AA, Jensen RI, Dekou V, et al. Developmental programming of aortic and renal structure in offspring of rats fed fat-rich diets in pregnancy. J Physiol. 2005;565:171–84.

    Article  CAS  PubMed  Google Scholar 

  46. Ainge H, Thompson C, Ozanne SE, Rooney KB. A systematic review on animal models of maternal high fat feeding and offspring glycaemic control. Int J Obes (Lond). 2011;35:325–35.

    Article  CAS  Google Scholar 

  47. Barnes SK, Ozanne SE. Pathways linking the early environment to long-term health and lifespan. Prog Biophys Mol Biol. 2011;106:323–36.

    Article  CAS  PubMed  Google Scholar 

  48. Dennison EM, Syddall HE, Sayer AA, Gilbody HJ, Cooper C. Birth weight and weight at 1 year are independent determinants of bone mass in the seventh decade: the Hertfordshire cohort study. Pediatr Res. 2005;57:582–6.

    Article  PubMed  Google Scholar 

  49. de Rooij SR, Roseboom TJ. The developmental origins of aging: study protocol for the Dutch famine birth cohort study on aging. BMJ Open. 2013. doi:10.1136/bmjopen-2013-003167.

  50. Desai M, Gayle DA, Casillas E, Boles J, Ross MG. Early undernutrition attenuates the inflammatory response in adult rat offspring. J Matern Fetal Neonatal Med. 2009;22:571–5.

    Article  CAS  PubMed  Google Scholar 

  51. Chen JH, Martin-Gronert MS, Tarry-Adkins J, Ozanne SE. Maternal protein restriction affects postnatal growth and the expression of key proteins involved in lifespan regulation in mice. PLoS One. 2009;4:e4950.

    Article  PubMed Central  PubMed  Google Scholar 

  52. Suter M, Bocock P, Showalter L, Hu M, Shope C, McKnight R, et al. Epigenomics: maternal high-fat diet exposure in utero disrupts peripheral circadian gene expression in nonhuman primates. FASEB J. 2011;25:714–26.

    Article  CAS  PubMed  Google Scholar 

  53. Suter MA, Chen A, Burdine MS, Choudhury M, Harris RA, Lane RH, et al. A maternal high-fat diet modulates fetal SIRT1 histone and protein deacetylase activity in nonhuman primates. FASEB J. 2012;26:5106–14.

    Article  CAS  PubMed  Google Scholar 

  54. Boyle KE, Newsom SA, Janssen RC, Lappas M, Friedman JE. Skeletal muscle MnSOD, mitochondrial complex II, and SIRT3 enzyme activities are decreased in maternal obesity during human pregnancy and gestational diabetes mellitus. J Clin Endocrinol Metab. 2013;98:E1601–9.

    Article  CAS  PubMed  Google Scholar 

  55. Borengasser SJ, Lau F, Kang P, Blackburn ML, Ronis MJ, Badger TM, et al. Maternal obesity during gestation impairs fatty acid oxidation and mitochondrial SIRT3 expression in rat offspring at weaning. PLoS One. 2011;6:e24068.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  56. Ma X, Zhu S. Metabolic syndrome in the prevention of cardiovascular diseases and diabetes–still a matter of debate? Eur J Clin Nutr. 2013;67:518–21.

    Article  CAS  PubMed  Google Scholar 

  57. Duque-Guimaraes DE, Ozanne SE. Nutritional programming of insulin resistance: causes and consequences. Trends Endocrinol Metab. 2013;24:525–35.

    Article  CAS  PubMed  Google Scholar 

  58. Garg M, Thamotharan M, Dai Y, Thamotharan S, Shin BC, Stout D, et al. Early postnatal caloric restriction protects adult male intrauterine growth-restricted offspring from obesity. Diabetes. 2012;61:1391–8.

    Article  CAS  PubMed  Google Scholar 

  59. Dolinsky VW, Rueda-Clausen CF, Morton JS, Davidge ST, Dyck JR. Continued postnatal administration of resveratrol prevents diet-induced metabolic syndrome in rat offspring born growth restricted. Diabetes. 2011;60:2274–84. Resveratrol is a plant-derived insulin-sensitizing modulator of the longevity-associated Sirtuin proteins. In growth-restricted offspring, administration of resveratrol reduces fat mass, restores dyslipidemia, and ameliorates insulin resistance and is therefore a potential therapy for early-onset T2D.

    Article  CAS  PubMed  Google Scholar 

  60. Bringhenti I, Schultz A, Rachid T, Bomfim MA, Mandarim-de-Lacerda CA, Aguila MB. An early fish oil-enriched diet reverses biochemical, liver and adipose tissue alterations in male offspring from maternal protein restriction in mice. J Nutr Biochem. 2011;22:1009–14.

    Article  CAS  PubMed  Google Scholar 

  61. von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial. Br J Nutr. 2010;103:549–55.

    Article  Google Scholar 

  62. Laitinen K, Poussa T, Isolauri E. Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomised controlled trial. Br J Nutr. 2009;101:1679–87.

    Article  CAS  PubMed  Google Scholar 

  63. Zeitler P, Hirst K, Pyle L, Linder B, Copeland K, Arslanian S, et al. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med. 2012;366:2247–56.

    Article  CAS  PubMed  Google Scholar 

  64. Gui J, Liu Q, Feng L. Metformin vs insulin in the management of gestational diabetes: a meta-analysis. PLoS One. 2013;8:e64585.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Kimberley D. Bruce declares that she has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Department of Metabolism and Aging, The Scripps Research Institute, Jupiter, FL, 33458, USA

    Kimberley D. Bruce

Authors
  1. Kimberley D. Bruce
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kimberley D. Bruce.

Additional information

This article is part of the Topical Collection on Pediatric Type 2 Diabetes

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bruce, K.D. Maternal and In Utero Determinants of Type 2 Diabetes Risk in the Young. Curr Diab Rep 14, 446 (2014). https://doi.org/10.1007/s11892-013-0446-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11892-013-0446-0

Keywords

Search

Navigation